학술논문

Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore.
Document Type
Article
Source
Clinical Infectious Diseases. 10/15/2022, Vol. 75 Issue 8, p1442-1445. 4p.
Subject
*RELATIVE medical risk
*COVID-19
*CONFIDENCE intervals
*COVID-19 vaccines
*DISEASE incidence
*REGRESSION analysis
*VACCINE effectiveness
*SEVERITY of illness index
*MESSENGER RNA
*OXYGEN therapy
*SOCIAL classes
*STATISTICAL models
*DATA analysis software
*POISSON distribution
Language
ISSN
1058-4838
Abstract
Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29–2.46) and 1.62 (95% CI, 1.43–1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25–0.70) times less likely to develop severe disease. [ABSTRACT FROM AUTHOR]